Premium Reports
Contact KLAS
 Download Report    Zoom in charts

Preferences

   Bookmark

Related Series

 No Related Series

 End chart zoom
Investor Newsletter April 2022 Investor Newsletter April 2022
* A page refresh may be necessary to see the updated image

Investor Newsletter April 2022

author - Justin Long
Author
Justin Long
author - Joshua Harris
Author
Joshua Harris
 
April 20, 2022 | Read Time: 9  minutes

Monthly overview of recent KLAS insights, upcoming reports, and industry happenings.

From the KLASroom

Understanding KLAS’ Vendor Differentiation

Since its founding, KLAS has always focused on differentiating vendors within set market segments. This is accomplished by interviewing healthcare professionals using our standard quantitative evaluations for healthcare software and services. KLAS also gathers other data to differentiate vendors; this data can include number of beds, practice size, number of facilities, number of procedures, daily census, home health visits, specialty type, project length, project cost, or other differentiators. This data helps providers and investors make informed purchasing or investment decisions regarding which technologies and services best suit their needs.

How Allscripts Stacks Up

overall satisfaction vs part of long term plans acute care emrAllscripts, recently acquired by Harris Health, can be used as a test case to show how KLAS’ differentiation data can be useful for providers and investors when deciding on technology solutions to acquire. In this data sample, Allscripts clients—who typically have a larger median bed count (acute facilities) or a larger number of physicians (ambulatory facilities)—report lower satisfaction and are less likely to say their EMR vendor is part of their long-term plans. Nearly 40% of ambulatory clinics and 30% of inpatient facilities that use Allscripts’ EMR systems are vulnerable to attrition. Many providers are looking for or have decided on alternative solutions.

Additionally, many Allscripts customers report frustration with sub-standard support, underdeveloped technology, integration issues, and a history of the vendor not sharing proposed product road maps. Some Allscripts customers who are staying with the vendor report feeling nervous about the Harris Health acquisition. Previous KLAS research around acquisitions in the healthcare IT market has shown that on average, about 40% of vendor acquisitions lead to lower overall customer satisfaction. Since Allscripts’ solutions are already suffering from long-term low customer satisfaction, this may lead current Allscripts customers to explore their options for alternatives sooner than they had previously expected to.

overall satisfaction vs part of long term plans ambulatory emr

The KLASifieds

KLAS Emerging Technology

Each week, dozens of new companies knock on the doors of provider organizations and health systems to present their latest innovative solutions. KLAS publishes 70–80 individual reports per year which provide early performance data on solutions that have been designated as emerging, disruptive, or innovative. To access the KLAS reports library, visit our website.

Recent Emerging Technology Report Sneak Peek

1upHealth FHIR Platform 
Emerging Technology Spotlight Report 2021

In 2021, new CMS rules came into effect that require CMS-regulated health plans to have a patient access API and a provider directory API. These rules are aimed at increasing the interoperability of personal health data, and they have prompted payers to look at new ways of sharing external information. This report evaluates 1upHealth‘s FHIR Platform, an interoperability solution designed to help payer customers meet government regulations and improve consent and authorization management.

1uphealth adoption of key functionality

Clarify Health Solutions Atlas Platform
Emerging Technology Spotlight Report 2022

Today, many healthcare organizations have a limited ability to aggregate, analyze, and generate actionable insights from big data. Properly harnessed, big data can enable provider and payer organizations to better analyze population health to unlock the potential of value-based care (VBC) and improve medical and financial decisions. Clarify Health Solutions strives for this through Atlas, their analytics platform that delivers insights via use-case specific software applications. This report seeks to validate customers’ experiences with Clarify Health’s analytics software.

clarity key performance indicators

Specialty Reports Published March 2022

KLAS typically publishes 70–80 specialty reports annually, providing market insights based on customer perceptions of and experiences with the vendor/consultant solutions they employ. KLAS also validates industry trends, emerging technologies, purchasing decision insights, and market energy. To view the full KLAS reports library, visit our website.

To purchase a KLAS report or find more information, contact the KLAS Investment Advisory team at investorservices@klasresearch.com.

Healthcare AI 2022:
Proven Outcomes with Data Science Solutions

The potential for artificial intelligence (AI) to transform healthcare has been both championed and challenged. In 2019, KLAS published our first research report on healthcare AI data science solutions, exploring healthcare organizations’ clinical, financial, and operational use cases and the early outcomes they were achieving. As an update to that research, this report examines how outcomes and customer satisfaction have evolved since then. Though progress has been somewhat limited by the financial and operational constraints of the COVID-19 pandemic, many of the organizations interviewed for this research found results by focusing on the right problems.

healthcare ai overall performance score

Smart Pumps 2022:
Where Are Organizations Investing for the Future?

The smart pumps market sees a high number of purchase decisions as old pumps wear out and new functionality becomes available, including bidirectional EMR interoperability, updated pump functionality, and better verification and documentation options. To determine where healthcare organizations are investing for the future, this report examines 40 recent or upcoming smart pump purchase decisions validated by KLAS between January 2020 and December 2021. For additional context, satisfaction data from current customers is also included.

smart pumps purchase decisions

Recently Released and Upcoming KLAS Specialty & Emerging Technology Reports

European EMR 2022:
Which Vendors Meet Customer Needs in a Rapidly Shifting Landscape?

In the past few years, there has been significant merger and acquisition (M&A) activity among EMR vendors who market in Europe. There has also been significant purchasing activity by healthcare organizations. This has created one of the world’s most dynamic EMR markets. From 2016–2020, KLAS validated over 300 EMR decisions that impacted over 1,200 inpatient facilities (comprehensive data for 2021 purchases not yet available). Using this data and customer feedback from 100 organizations, this report examines the customer satisfaction, market share, and recent market energy of European EMR vendors and evaluates which are best meeting customer needs in this competitive market.

Price Transparency 2022:
Hospital Perceptions of CMS Regulation

As of January 1, 2021, all US hospitals must comply with CMS’ price transparency regulation, which stipulates that hospitals must provide clear, accessible pricing estimates online for at least 300 different shoppable services. Many healthcare organizations have expressed that a variety of challenges make this mandate difficult to meet. In this perception report, KLAS interviewed 66 revenue cycle leaders to understand how hospitals are responding to the regulation and their future plans around price transparency. Going forward, KLAS intends to continue to measure and provide insights into the consumerization of healthcare.

Revenue Integrity/Underpayment Services 2022
Finding the Firm That’s Right for Your Organization

Overall, healthcare organizations are highly satisfied with the firms they engage to tackle difficult revenue-collection issues, such as underpayments, denials, and complex government reimbursement requirements. However, different firms focus on different revenue integrity areas, making side-by-side comparisons difficult. To help organizations identify which firms best fit their needs, this report looks at how well firms educate clients on ways to proactively avoid missed revenue, highlights firms’ client-validated areas of expertise, and examines each firm’s specific strengths and opportunities for improvement.

CorroHealth Autonomous Coding:
Emerging Technology Spotlight 2022

More and more healthcare organizations are evaluating the viability of autonomous coding to increase efficiency and reduce overhead expenses. CorroHealth’s autonomous coding product offers provider organizations a solution that streamlines coding workflows to reduce labor-intensive tasks and improve productivity. This report looks to validate the outcomes that CorroHealth’s customers have experienced and examine customers’ satisfaction with the product.

Codoxo:
Emerging Technology Spotlight 2022

Each year, billions of dollars are put toward healthcare, yet much of it is lost to fraudulent claims and bad payments. To help payer organizations control costs, Codoxo’s Forensic AI Platform provides actionable insights that identify existing or emerging fraud, waste, and abuse (FWA) issues. This report looks to validate the Codoxo customer experience.

Damo Consulting Digital Transformation Consulting:
First Look 2022

Healthcare provider and payer organizations are increasingly concerned with the consumer experience and are working to improve digital engagement. As part of this effort, some organizations enlist consulting firms to help plan, manage, and improve consumer experiences by digital means. Through digital transformation services, consultants help define needs and develop digital road maps. This report evaluates the experiences of organizations that have engaged with Damo Consulting on a digital transformation project.

Phox Health:
Emerging Technology Spotlight 2022

Healthcare organizations can face challenges while maintaining pharmacy financial margins, reducing medication abandonment, and delivering medications safely and securely to patients. Providing optimal care quality to virtual care patients requires timely access to prescription-delivery products and other healthcare products. This report offers a first look at Phox Health, a healthcare solution provider who partners with medical couriers to deliver medications across health system departments and to patients.

ScribeAmerica Speke:
Emerging Technology Spotlight 2022

Physician burnout from overwork is a growing concern for hospitals and health systems. In the wake of the COVID-19 pandemic and with the ongoing demands on clinicians, innovative solutions that help clinicians shift away from the computer and back to the bedside are more important than ever. This report seeks to validate the experiences of healthcare organizations that use the Speke solution, which was created by ScribeAmerica Speke’s sister company, SoundLines.

To make a purchase or find more information on KLAS reports, contact the KLAS Investment Advisory team at investorservices@klasresearch.com.

Market Activities Impacting Investments

Growth Equity Deal Activity Rises Sharply in 2021

The surge in growth equity deal activity has also been driven by private equity investors seeking exposure to higher growth companies at an earlier stage than buyouts, especially in sectors where mature companies are trading at extremely high multiples.

Three Philosophies for Implementing ESG Strategies

ESG philosophy approaches can frame implementation and substantiation guidance, which can be used to help align expectations around what sustainability-oriented programs should look like when investing in companies of various sizes, maturities, and operational complexity.

The Trust Factor of Organizations Becomes a Key Governance Issue

Managing and measuring trust requires a robust understanding of trust-driving activity throughout an enterprise along with a solid grasp of the perspectives and priorities of different stakeholders.

Congress Set to Extend Telehealth Coverage for 151 Days

Congress should move beyond extensions and make the telehealth provisions established during the COVID-19 pandemic permanent.

Hospital-at-Home Playbook

Lessons from Mayo Clinic, Michigan Medicine, and Presbyterian Health.

Current Series B Trends

Series B rounds are getting bigger and have signaled significant scaling actions for the companies receiving them. Series B rounds are happening across a variety of sectors but are still the largest in the biotech sector.

How Does KLAS Support Investors?

Investors who are familiar with KLAS but have not yet had the opportunity to speak with a member of our Investment Advisory team can visit our webpage at klasresearch.com/investment-professionals. Here, investors can gain a better understanding of how KLAS supports the investor-sponsor community.

To gain access to KLAS data or schedule your next custom diligence project, contact a member of our KLAS Investment Advisory team today at investorservices@klasresearch.com.

Upcoming KLAS Events

KLAS International Summit 2022

Registration is open

June 7–8 | Vila Vita Parc Resort, Algarve, Portugal

KLAS 2022 Digital Health Investment Symposium (DHIS)

September 13–14 | Park City, Utah

For information on all KLAS events, including those coming soon, visit the KLAS events page at klasresearch.com/events page.

Follow KLAS on social media: LinkedIn | Facebook | Twitter

author - Natalie Jamison
Designer
Natalie Jamison
author - Andrew Wright
Project Manager
Andrew Wright
 Download Report

This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2024 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.

​